Will the Phase 2 trial "Effects of Treatments on Atopic Dermatitis" reach primary completion on or before Jan 1, 2027?

Resolves Yes if ClinicalTrials.gov record NCT01631617 (National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)) shows an actual primary completion date on or before Jan 1, 2027. Registered date at generation: Jan 1, 2027.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Jan 1, 2027, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.